|
English
|
正體中文
|
简体中文
|
總筆數 :2856704
|
|
造訪人次 :
53756867
線上人數 :
2376
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"king c h r"的相關文件
顯示項目 1-4 / 4 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-12-18T08:38:51Z |
In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan
|
Chen Y.-H.; Liu C.-Y.; Lu J.-J.; King C.-H.R.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-03-27T05:30:05Z |
In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan
|
PO-REN HSUEH;King C.-H.R.;Lu J.-J.;Liu C.-Y.;Chen Y.-H.; Chen Y.-H.; Liu C.-Y.; Lu J.-J.; King C.-H.R.; PO-REN HSUEH |
| 國立臺灣大學 |
2016 |
HIGHER GENETIC BARRIER REVEALED IN HCV GT-1B/2/4/6 SUBJECTS THAN GT-1A PATIENTS - A PROOF OF CONCEPT TRIAL OF TG-2349 (FURAPREVIR)
|
Yeh, C. -T.; Hsu, S. -J.; Hu, T. -H.; Liu, C. -J.; Tsai, C. -E.; Chen, C. -M.; Chang, L. -W.; Lin, C. -C.; King, C. -H. R.; Hsu, M-C.; 徐士哲; 劉俊人 |
| 國立臺灣大學 |
2016 |
TG-2349, A POTENT PROTEASE INHIBITOR, PLUS PEGIFN/RBV PROVIDES EXCELLENT VIROLOGICAL RESPONSES FOR HARDER-TO-TREAT SUBPOPULATIONS OF HCV-1B NON-CIRRHOTIC PATIENTS
|
Yu, M. -L.; Hsu, S. -J.; Yeh, C. -T.; Hung, C. -H.; Chen, M. -Y.; Chen, P. -J.; Huang, Y. -H.; Cheng, P. -N.; Chen, C. -M.; Chang, L. -W.; Lin, C. -C.; Sheen, F.; King, C. -H. R.; Kuo, E.; Hsu, M. -C.; 徐士哲; 陳培哲 |
顯示項目 1-4 / 4 (共1頁)
1
每頁顯示[10|25|50]項目
|
